|
All Enlarged Prostate Special Reports
|
Two-Drug Options for BPH
n the 1980s, state-of-the-art treatment for men with benign prostatic hyperplasia (BPH) who experienced symptoms consisted of a transurethral prostatectomy. Beginning in the 1990s, medical treatment with either an alpha blocker to relax the smooth muscle in the prostate or a 5-alpha reductase inhibitor to shrink the prostate (or the two combined) became state-of-the art treatment. But today, advances in our understanding of BPH are helping doctors tailor therapy to a man's specific lower urinary tract symptoms and their causes. Often, that tailored treatment requires more than one medication, and one of those medications may not be a traditional BPH drug. More...
|
|
PVP or TURP for BPH?
If you've tried medication for benign prostatic hyperplasia (BPH) and it hasn't controlled your symptoms, it's time to consider a different approach. That used to mean surgery to remove excess prostate tissue. But today you have a number of less invasive options, including a new laser procedure called photoselective vaporization of the prostate (PVP) or GreenLight laser therapy.
More...
|
|
In the Pipeline: New Treatments for BPH
Current medical treatment for benign prostatic hyperplasia (BPH, or an enlarged prostate) relies on alpha-1-adrenergic blockers (alpha-blockers), which relax muscles in the prostate, or 5-alpha-reductase inhibitors, which lower androgen levels within the prostate. This Special Report reviews other promising BPH treatment currently in the pipeline.
Experimental Drugs: Some of the medications under investigation for BPH include:
More...
|
|
What Does It Mean? PSA Terminology Explained
The American Urological Association recommends an annual PSA (prostate-specific antigen) test to screen them for prostate cancer beginning at age 50. Recently, researchers have developed several ways to improve the PSA test's accuracy. In this Health Alert, Johns Hopkins experts explain PSA density, PSA velocity, and other PSA measurements.
PSA is an enzyme produced almost exclusively by the glandular cells of the prostate and normally only very small amounts of PSA are present in the blood.
More...
|
|